We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tactus AI Unveils Humanoid Assistant for Clinical Laboratory Bench Work

By LabMedica International staff writers
Posted on 27 Jul 2026

Clinical laboratories continue to face sustained staffing shortages even as test volumes and complexity rise. More...

Many facilities have automated instruments but lack enough qualified bench operators to keep them running across extended shifts. To help address this gap, Tactus AI has unveiled a new humanoid lab assistant at ADLM 2026 that works directly at the bench to run existing analyzers under a laboratory’s validated standard operating procedures.

Elsie by Tactus AI is an autonomous two-armed assistant is built for clinical bench work and is being demonstrated on the ADLM Clinical Lab Expo floor. The system is paired with Tactus Lab Orchestration software to plan and execute multi‑step protocols across robots, instruments, and staff. Elsie is positioned to support laboratories that want to increase instrument uptime without retooling benches or replacing analyzers.

Elsie combines tactile and force sensing with depth perception and machine vision, coordinated by a proprietary learning software suite. The platform’s skill library holds validated capabilities, each certified against a customer’s standard operating procedures (SOPs) before deployment. Across its skills, Elsie is designed to monitor instruments and flag exceptions, move samples and consumables, run tests to validated SOPs, clear first‑line faults, perform routine cleaning and calibration tasks, and log all actions to the orchestration platform.

Implementation is structured around customer quality oversight. Tactus builds a high‑fidelity digital twin of the bench so Elsie’s policies can be trained and stress‑tested across hundreds of simulated runs prior to any live samples. Each skill is then validated on site against acceptance criteria, and nothing runs live until the laboratory’s own quality team approves it. The platform operates within enterprise security and privacy standards, including ISO 27001, SOC 2 Type II (July 2026), and compliance with HIPAA and GDPR. The system supports laboratory operations and is not offered as a diagnostic device.

Tactus is selecting three to five launch laboratories in 2026, with initial pilots at U.S. academic medical centers. Engagements begin with a four‑domain readiness review—physical site, instruments, workflow, and data systems—followed by a Robot‑Readiness Assessment delivered within 30 days that outlines gaps, a skill roadmap, and pilot scope. Elsie is on view at ADLM 2026 Booth 2616 in Anaheim through July 30.

“Labs aren’t short on automation. They’re short on hands. Most labs own instruments that could run far more hours than they do. What’s missing is a trained operator to keep them running. That’s what we built Elsie to do, and she does it on the bench using the SOPs a lab already has, instead of asking the lab to rebuild around a robot,” said Michael Quick, Chief Commercial Officer of Tactus AI.


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.